fda compounding glp-1 enforcement news National Hispanic Medical Association | The federal government is stepping up to stop counterfeit weight-loss drugs. In 2025, bipartisan lawmakers urged stronger FDA GLP-1 Compounding Crackdown

Whether the goal is improving blood sugar stability, reducing reliance on reactive eating, or achieving weight balance, GLP-1 peptide therapy can provide a valuable tool

Standard mineral salts can sometimes cause digestive discomfort or compete with other minerals (like copper or calcium) for absorption

As the public may recall, Hims & Hers began selling various Eli Lilly drugs on their platform last monthboth branded forms of tirzepatideincluding Zepbound, a GLP-1 receptor agonist approved by the FDA for weight loss, and Mounjaro, which is not approved for weight loss but for the treatment of type 2 diabetes

CKD affects approximately 37 million adults in the US and is a common complication of diabetes, with approximately 40% of people with type 2 going on to develop the condition

GLP-1s are medications designed to reduce blood sugar in people with Type 2 diabetes